🇺🇸 FDA
Pipeline program

Mounjaro 5 mg solution for injection in pre-filled pen, Mounjaro 2.5 mg solution for injection in pre-filled pen

Approved small_molecule active

Quick answer

Mounjaro 5 mg solution for injection in pre-filled pen, Mounjaro 2.5 mg solution for injection in pre-filled pen for Obesity is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
The George Institute
Indication
Obesity
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials